In an important decision announced late on Friday last week, the Centers for Medicare & Medicaid Services (CMS) announced that it had agreed to cover costs associated with genetic/genomic testing for Medicare patients with many advanced forms of cancer. Specifically, according to a report on the Reuters web site, CMS has made a “national coverage […]
↧
